Clinical Trial Update: SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update investigates whether SGLT2 inhibitors can prevent liver complications in patients with chronic hepatitis B and diabetes mellitus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hepatitis B

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Chronic Hepatitis B | Phase 4 | Status: RECRUITING